Koninklijke Philips had ten patents in mobile during Q1 2024. The patents filed by Koninklijke Philips NV in Q1 2024 include technology for providing personalized guidance to patients receiving obstructive sleep apnea treatment based on their personality type and mobile app usage, a system for CPR decision support using PPG signals and motion detection, a user device for wireless communication with multiple network elements using spatial or directional beams, and a method for providing feedback on oral care habits to users using recorded sessions. GlobalData’s report on Koninklijke Philips gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Koninklijke Philips grant share with mobile as a theme is 50% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: System and method to predict personality type to deliver cpap therapy support (Patent ID: US20240071587A1)
The patent filed by Koninklijke Philips NV describes a therapy management system that utilizes mobile app usage data to determine a patient's personality type and provide personalized treatment guidance for obstructive sleep apnea. The system extracts features from mobile app logs, determines the patient's personality type, and generates specific messages based on this type. These messages are then communicated to the patient's mobile device. The system can further receive device usage data and patient response data to modify the treatment guidance accordingly, ensuring a tailored approach to therapy management.
The therapy management system outlined in the patent claims involves extracting mobile app usage features, determining a patient's personality type, and generating personalized treatment guidance based on this information. The system utilizes a pretrained classification model for personality type detection and can adjust the content, frequency, and timing of messages based on device usage data and patient responses. By incorporating these elements, the system aims to enhance the effectiveness of obstructive sleep apnea treatment by providing individualized support and guidance to patients throughout their therapy journey.
To know more about GlobalData’s detailed insights on Koninklijke Philips, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.